Collaboration Mode
Joint Development
  • Cooperative development
    1. Investment and development, equity sharing:
    Suitable for investment institutions, sales teams, and individuals, using DiQi Pharma as the MAH platform
    2. Technical cooperation and equity sharing:
    Joint development of key technologies, including joint development between upstream active pharmaceutical ingredients and downstream pharmaceutical production enterprises
    3. Strategic cooperation:
    All parties complement each other's advantages, form strategic alliances, and achieve mutual benefit and win-win results

  • Technology authorization/technology transfer
    1. Independent intellectual property rights and technology authorization:
    Existing technology and intellectual property authorization research and production
    2. Technology transfer:
    Mature technology package and equity transfer
  • Entrusting research and development, production
    1. CMC research contract development:
    Innovative drugs, improved innovative drugs, generic drugs
    2. Commissioned production of high-end preparations:
    Long acting microspheres and implants

  • Consultation and registration services
    Consultation and registration services
    1. Consultation on drug related technology and regulations
    2. Drug and excipient registration services
    Product Agency
    1. DiQi MAH varieties: high-end formulations, improved innovative drugs
    2. Biodegradable materials: PLGA, PLA, etc
  • Contact Information
    Address:8 Luoxuan 3rd Road, Guangzhou International BIO-island
    Main telephone number:020-32227031
    Fax:020-32227031
    Email:gzdq@gzdqyy.com
  • Customer Service
    Postal Code:510300
    Business Consulting:18122367150 13602749876
    Complaints Hotline:020-32227031
    Complaint Email:diqiyjx@gzdqyy.com
Official WeChat
Official WeChat
Copyright©2021 Guangzhou DiQi Pharmaceuticals Co., Ltd 粤ICP备2024318179号 粤公网安备44011202002899号 Powered By Vancheer
top